Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database-Reference-Cited by-同舟云学术

Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database

Published:2016-05 Issue:5 Volume:42 Page:744-750
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology (EJSO)
language:en
Short-container-title:European Journal of Surgical Oncology (EJSO)

Author:

Wolff I.,May M.,Hoschke B.,Zigeuner R.,Cindolo L.,Hutterer G.,Schips L.,De Cobelli O.,Rocco B.,De Nunzio C.,Tubaro A.,Coman I.,Feciche B.,Truss M.,Dalpiaz O.,Figenshau R.S.,Madison K.,Sánchez-Chapado M.,Santiago Martin M.D.C.,Salzano L.,Lotrecchiano G.,Shariat S.F.,Hohenfellner M.,Waidelich R.,Stief C.,Miller K.,Pahernik S.,Brookman-May S.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference20 articles.

1. EAU guidelines on renal cell carcinoma: 2014 update;Ljungberg;Eur Urol,2015

2. A review of integrated staging systems for renal cell carcinoma;Meskawi;Eur Urol,2012

3. Conditional survival predictions after nephrectomy for renal cell carcinoma;Karakiewicz;J Urol,2009

4. Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma?;Brookman-May;Expert Rev Anticancer Ther,2010

5. Adjuvant therapy in renal cell carcinoma-past, present, and future;Janowitz;Semin Oncol,2013

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive value of m6A regulators in prognosis and immunotherapy response of clear cell renal cell carcinoma: a bioinformatics and radiomics analysis;Journal of Cancer Metastasis and Treatment;2024-06-28

2. Construction of a 12-Gene Prognostic Risk Model and Tumor Immune Microenvironment Analysis Based on the Clear Cell Renal Cell Carcinoma Model;Cancer Control;2024-01

3. Multi-omics comprehensive analysis of renal clear cell carcinoma to distinguish subtypes with different molecular characterizations and therapeutic strategies;2023-07-24

4. Integrated analyses reveal the prognostic, immunological features and mechanisms of cuproptosis critical mediator gene FDX1 in KIRC;Genes & Immunity;2023-07-10

5. Metastasis in renal cell carcinoma: Biology and treatment;Advances in Cancer Biology - Metastasis;2023-07